For instance, the KDIGO 2021 guidelines recommend that patients with nephrotic syndrome and positive anti-PLA2R antibodies may be diagnosed with membranous nephropathy without biopsy[6]. Here, PLA2R1 is linked to membranous glomerulonephritis.